Fig. 7From: circTUBGCP5 promotes liver cancer progression and glycolysis by up-regulating the expression of ACSL4CircTUBGCP5 enhanced LCa tumor growth in vivo. A Tumor volume and B tumor weight were monitored in the sh-NC group (n = 5) and sh-circTUBGCP5 group (n = 5). C qRT–PCR analysis of the circTUBGCP5 level. D Western blot and E IHC analysis of the ACSL4, c-myc, and GLUT1 protein levels in different group xenografts, the scale bar represents 100 µm. Data were shown as mean ± SD. **P < 0.01, ***P < 0.001Back to article page